Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 3154 (LINC03154) is a human long intergenic non-coding RNA (lincRNA), defined as a transcribed RNA molecule longer than 200 nucleotides that does not overlap with annotated protein-coding genes[1][5]. LincRNAs frequently regulate chromatin states, transcription of nearby or distant genes, and nuclear architecture[1][5]. Although thousands of lincRNAs have been annotated and a subset shown to modulate gene expression or disease, LINC03154 itself has not been specifically characterized in terms of function, disease relevance, or druggability in current scientific literature. It remains one of many human lincRNAs whose biological roles are largely unstudied.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 3154 (LINC03154).